Positive RSI Divergence on SmallCap 100 Index. Some bounce expected. Resistance is at 6555 and 6950. Note that 6555 is also the 200 MA on weekly. Slightly Risky buy on a closing above 6555. Possibly safe to buy on a closing above 6950. Downside can possibly accelerate towards 5400 if 5650 is broken. Huge downside possible below 5400.
LSCC - $1B Mkt Cap, 1.2B Ent Value, no dividend. Profitable earnings all 2018, not prior. Has IP, growth, strong technology future in smart connectivity, video, and SaS, or high value logic devices. Strong recovery from recent drop at 238 Fibretracement and climbing. About to report strongest earnings, albeit $0.08/share, which is up 700% over prior Q1...
This is an investment for me but i still like to look at the charts and hence why im looking at the weekly Price looks like it is coiling up and has retraced approximately 50% from the highs. I think there is a high probability we we will see the all time highs broken this year with 8-8.5p being reached as a minimum Good news flow due on there current assets and...
TSX: TSX:HRT OTC:HRTFF * Harte Gold Corp is an Ontario Canada-based company engaged in the acquisition, exploration and development of mineral resource properties with a focus on gold properties located in the Province of Ontario. It has interests in gold exploration projects, including Sugar Zone Property, which is located approximately 60 kilometers east of...
SMSLIFE CMP 490 STOP 400 LONG SUGGESTED ABOVE 530 TARGET OPEN LOGIC: WEEKLY CHART - Stock has formed a sort of reverse H&S pattern. Fundamentally EPS has been witnessing triple digit annual growth for the last couple of quarters Date EPS %Chg Sales(Cr) %Chg Sep-18 14.59 +334% 89.2 +75% Jun-18 10.16 +196% 59.9 ...
CMP 484 Long suggested above 495. Stop 420 Target Open Logic: Weekly chart 1) Passes MM trend template. 2) Price currently bounced from value zone and trading just above R4 cam pivots with good volumes. 3) Price has pierced the trend line resistance and has bounced back after making the first test with good volumes. 3) Fundamentally has been clocking triple digit...
RPD FEYE Retest of recent low. Big boys taking and thrashing out more sellers.
Evoqua Water Technologies Corp. is focused on providing water treatment solutions. The Company is offering services, systems and technologies to support customers' full water lifecycle needs. The Company offers a comprehensive portfolio of differentiated, proprietary technology solutions. The Company operates through three segments Industrial, Municipal and...
MDA saw lots of volume in the past weeks and has risen more than 400% percent followed by 50% correction. The volume has decreased since then during the correction. However, it is still significant (2.6 million for the last 24 hours) compared to its market cap (30 million). The fundamentals of the project are very promising and it has already functioning product...
My first recommendation is Fluence Corporation. Fluence corporation is a global leader in mid-sized, decentralized water and wastewater solutions. From a fundamental and macro view , I like the stock as water, wastewater treatment and sustainability is an increasingly important topic in society. Increasing expenditure in water treatment is inevitable, China for...
NASDAQ:APEN saw a break out today and the move was impressive. I believe we saw the first Minor 5 Wave Cycle in a longer trend. We should see and extension of today's rally because WAVE 1 & WAVE 2 broke the Fibonacci Level of 1.618. APEN has been in a long Decline since 2008! Key Fibonacci Extension levels that I am eyeing from the extension of WAVES 1 &...
The tax reform of Trump makes an investment in the USA not only useful from a tax point of view. As the global economic crisis of 2018-2022 with hire interest rates and sinkig Bonds the pension sector such as life insurance, will come in massive trouble. The capital from this sector can only flow into the next liquid market and these are by far the stock exchanges...
Prudent Drug Discovery Company Low market cap ( appox £13m at time of writing ). Issues shares very rarely ( last placing nearly four years ago ). Has material interest in its work from larger partners ( Pharmaxis ). Sold interest in LOXL2 programme for £5m to Pharmaxis in December. Pharmaxis continues to fund and develop LOXL2 inhibitors and Synairgen retains...
Very low share supply (15million), niche market (airlines/air travel/aeronautics), and a very healthy chart. While we can't say for sure whether Aeron will succeed in establishing itself as a company long term, there are a lot of catalysts priming this one for a very solid and sustained run. I'll follow this up with a shorter interval or two once the chart matures...
Norwegian smallcap biotech Nordic Nanovector recently had a major capitulation event after touch the bottom of yearlong downtrend fueled by weak biotech sentiment on Oslo stock exchange as well as a pronounced distrust to CEO in the norwegian investor community. After former CEO Lugi Costa resigned sentiment has changed drastically, and the stock looks poised to...
I feel crazy for publishing this post but as a pact to myself that I’m publishing every trade I make to keep a journal, I must go on! Following BTC’s strong rebound on 06/02, we have seen the sentiment cascade over all crypto markets. I have even seen a few coins pump over 100% on Bittrex which tells me this kind of pumping is beginning to return. Looking at AUR...
Keep in mind LTCUSD currently sits at #5 and its market cap ($12.3B) is nearly half that of the next coin up (BCHUSD @$23.4B). It’s had a nice run the last few days, but is still very much susceptible to the ups and downs of the lead coins BTCUSD and ETHUSD With that said, it’s still in a position of strength. RSI is not red-lining, volume is healthy and the tech...